Skip to main content

Cypress Capital Group

SEC CIK
0001341748
Latest filing
Aug 5, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Cypress Capital Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
111,026
Value
$27.9M
% of portfolio
2.6%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Cypress Capital Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026111,026$27.9M2.6%+591+0.5%AddedHolders
Q1 2026110,435$24.0M2.7%−2,179−1.9%ReducedHolders
Q4 2025112,614$25.7M2.9%+4,661+4.3%AddedHolders
Q3 2025107,953$25.0M3.0%−517−0.5%ReducedHolders
Q2 2025108,470$20.1M2.5%+878+0.8%AddedHolders
Q1 2025107,592$22.5M3.0%−4,754−4.2%ReducedHolders
Q4 2024112,346$20.0M2.4%−1,451−1.3%ReducedHolders
Q3 2024113,797$22.5M2.5%−134−0.1%ReducedHolders
Q2 2024113,931$19.5M2.3%−928−0.8%ReducedHolders
Q1 2024114,859$20.9M2.5%+3,938+3.6%AddedHolders
Q4 2023110,921$17.2M2.2%−1,061−0.9%ReducedHolders
Q3 2023111,982$16.7M2.4%−640−0.6%ReducedHolders
Q2 2023112,622$15.2M2.2%−3,859−3.3%ReducedHolders
Q1 2023116,481$18.6M2.8%−8,739−7.0%ReducedHolders
Q4 2022125,220$20.2M3.1%+5,598+4.7%AddedHolders
Q3 2022119,622$16.1M2.7%−5,396−4.3%ReducedHolders
Q2 2022125,018$19.1M2.9%−5,711−4.4%ReducedHolders
Q1 2022130,729$21.2M2.6%+10,260+8.5%AddedHolders
Q4 2021120,469$16.3M2.0%−14,352−10.6%ReducedHolders
Q3 2021134,821$14.5M2.0%+2,250+1.7%AddedHolders
Q2 2021132,571$14.9M2.0%−210.0%ReducedHolders
Q1 2021132,592$14.3M2.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.